BDTX
Black Diamond Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Black Diamond Therapeutics (BDTX) Stock: Buy, Sell, or Hold?
$1.61
+0.02 (+0.94%)
▲
5d:
-15.26%
30d:
-4.17%
90d:
-20.3%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
46/100
Position
OVERSOLD
30-Day Fair Range
$1.68 – $1.93
Position: OVERSOLD
Forward P/E & Valuation
-1.5x
Next 12M consensus est.
Wall Street Target
$10.86
+574.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.58 / $1.96
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BDTX is down 15.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BDTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BDTX is currently trading at $1.61, which is considered oversold relative to its 30-day fair value range of $1.68 to $1.93.
Technical Outlook: Technically, BDTX is in a uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BDTX scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.86 (+574.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDTX is in a uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BDTX scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.86 (+574.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.68 -
$1.93
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Trading Range & Key Levels
30-Day Trading Range
$1.68 -
$1.93
Current vs Trading Range
OVERSOLD
Support Level
$1.58
Resistance Level
$1.96
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 574.4% below Wall St target ($10.86)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.45
Wall Street Target
$10.86
(+574.4%)
Share BDTX Analysis
Share this live BDTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BDTX)
Bullish
7 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
6 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Black Diamond Therapeutics reported a loss in Q3, missing analyst estimates, but also announced positive updated Phase 2 results for sileurtinib and FDA feedback supporting potential registration in 1L EGFR-NCM NSCLC.
Key Retail Themes:
Company earnings
Clinical trial results
FDA feedback
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BDTX Research Pages
